ArticleAnnals of hematology2022

Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory.

Sandrine Saugues et al.PubMed ↗Publisher ↗

No numbers read from the abstract.